STUDY ANNOUNCEMENT
Inflammation and Exercise Recovery Study
Interested in your what happens to your body when you exercise?
We are seeking adults 18-65 years who are currently exercising between 1 and 3 times per week for a study assessing the effectiveness of an investigational product designed to improve exercise recovery.
Please note: This page is a summary of the study outline and participant requirements. A full Participant Information Sheet with detailed information will be provided to you before you are asked to give your consent to participate.
How long is the study, and when does it start?
Your involvement in this study will be required for approximately 9 weeks, 8 of which you will be required to take the study product each day. We are recruiting on a rolling basis which means that your individual start date is flexible.
For your convenience, our RDC Clinic is open Monday to Saturday from 6.30am.
Please see below for more information. You can also register your interest using the form at the bottom of this page.
About the product you’ll help investigate…
This study is designed to examine the effects of a milk-based protein supplement, called Maolactin, on exercise recovery and inflammation. The supplement contains a blend of functional proteins formulated to lower inflammation and enhance muscle recovery. This innovative product is aimed at assisting athletes of all skill levels, as well as the elderly, in improving mobility and enhancing exercise recovery.
The product will be supplied in capsule form, and participants will be asked to take 2 capsules daily for 8 weeks.
As this study is placebo-controlled, you may or may not be allocated the active product. The product is allocated randomly on a chance basis, and you will not know which product group you have been allocated to. This is to ensure that no unintentional bias can impact the results.
In this study, there is 1 active group and 1 placebo group, so you will have a 50% chance of receiving the active product.
Placebos are designed to look like the real product being studied except they do not contain the active ingredient. Using a placebo helps us to be confident that any effects we measure in the active group really are due to the active ingredient and not due to the body’s own reaction to a perceived treatment.
Why is this study being conducted?
Exercise has many beneficial effects that include weight loss, increased muscle mass, decreased risk of disease, including cardiovascular disease, and improved mental health. However, it is possible, even with light exercise, to trigger an inflammatory response within the muscle. Repetitive movement, that involves the lengthening of muscle, causes a disruption of the fibres within muscle, resulting in the release of inflammatory compounds and the production of reactive oxygen species.
Those who experience inflammation and/or muscle and joint pain following exercise turn to aids to assist and improve their activity level. These can include prescription and over the counter medications or herbal supplements. Whilst some of these may be effective, there can be associated side effects, some being ineffective, poorly tolerated, and/or create dependency. Therefore, it is important to develop aids that have little to no side effects while also addressing the cause of the problem.
What is required of participants?
Your involvement in the study will be for approximately 9 weeks. You will be required to attend our clinic (in Fortitude Valley, Brisbane) 6 times during the study. There will be 3 consecutive visits at baseline and 3 more at the end of the study.
During the study, you will be asked to:
- Take the study product (in capsule form) daily for 8 weeks
- Attend our clinic 6 times
- Provide at least 1 blood sample at each visit
- Complete 1-repetition max (1-RM) leg press test
- Perform 80% 1-RM leg press test (3 sets of 10) then a 70% 1-RM leg press to failure
- Complete a series of short questionnaires at several points throughout the study
- Complete a diet recall for a total of 6 days throughout the study
The information we collect during the study will enable the investigators to assess the product’s tolerability and efficacy in improving inflammation and muscle recovery.
To make the timings of these visits as convenient as possible for you, we are recruiting on a rolling basis. This means that your individual start date is flexible. The RDC Clinic is open 6 days a week (from 6.30am).
Please note: This page is a summary of the study outline and participant requirements. A full Participant Information Sheet with detailed information will be provided to you before you are asked to give your consent to participate.
Payment
Upon completion of the study requirements, you will be eligible for a $350 reimbursement for your time and travel expenses. The payment will be made via direct deposit to your nominated bank account once all study requirements have been met. You can also elect to be reimbursed with vouchers.
Pro rata payments are also available in the case of early withdrawal.
If you are interested in participating, we’d love to hear from you. Please register your interest by answering the questionnaire and completing the form on this page…we’ll then get in touch to screen you for eligibility.
Study Location
Our clinic is centrally located on Level 3, 252 St Pauls Terrace, Spring Hill.
We offer free undercover parking directly next door under the Kennigo Hotel, 22 Kennigo Street, Spring Hill.
Getting to Us
- Private Transport: free undercover parking available at Kennigo Hotel Car Park as well as metered street parking (availability for street parking is day/time dependent). Please enter 22 Kennigo Street, Spring Hill into your GPS.
- Train: Fortitude Valley Train Station (350m away)
- Bus: multiple bus stops within close proximity
BMI Calculator
Check if you can register to take part…
- Adults 18-65 years of age
- Generally healthy with no uncontrolled or serious illnesses
- BMI 19-29.9 kg/m2 (you can check this on the BMI calculator on this page)
- Undertaking low to moderate exercise (between 1 and 3 resistance exercise sessions per week)
- Able to provide informed consent
- Able to commit to completing the study requirements
Please register your interest by answering the questionnaire and completing the form on this page… we’ll then get in touch to screen you for suitability.
Please note: This page is a summary of the study outline and participant requirements. A full Participant Information Sheet with more detailed information will be provided to you before you are asked to give your consent to participate.
Ethics approval and privacy
This RDC Clinical study has been approved by the Bellberry Human Research Ethics Committee under Approval Number: 2024-03-328. The study is also registered on the clinicaltrials.gov under Registration Number: NCT06436781.
Trained trial coordinators will supervise your progress throughout the study. Your results will be made available to you at the conclusion of the study. Any of your personal information collected during the study will be kept in the strictest confidence.